HDC Board Member Forms Prognostic Test Startup | GenomeWeb
NEW YORK (GenomeWeb News) – Health Discovery Corp. said today that Richard Caruso, one of the firm’s board members, has resigned his position to form a new firm that intends to develop a breast cancer prognostic test based on HDC’s support vector machine technology.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.